Δημοσιεύσεις

Κατάλογος ενδεικτικών δημοσιεύσεων του τμήματος Ιατρικής ΑΠΘ σε διεθνή επιστημονικά περιοδικά κατά τα τελευταία 5 έτη.

Export 173 results:
Συντάκτης Τίτλος Τύπος [ Έτος(Asc)]
Φίλτρα: Συντάκτης is Roilides, Emmanuel  [Clear All Filters]
2019
Karampatakis, T., Tsergouli K., Politi L., Diamantopoulou G., Iosifidis E., Antachopoulos C., et al. (2019).  Molecular Epidemiology of Endemic Carbapenem-Resistant Gram-Negative Bacteria in an Intensive Care Unit.. Microb Drug Resist. 25(5), 712-716.
Karampatakis, T., Tsergouli K., Politi L., Diamantopoulou G., Iosifidis E., Antachopoulos C., et al. (2019).  Polyclonal predominance of concurrently producing OXA-23 and OXA-58 carbapenem-resistant Acinetobacter baumannii strains in a pediatric intensive care unit.. Mol Biol Rep. 46(3), 3497-3500.
Pérez-Nadales, E., Gutiérrez-Gutiérrez B., Natera A. M., Abdala E., Magalhães M. Reina, Mularoni A., et al. (2019).  Predictors of mortality in solid organ transplant recipients with bloodstream infections due to carbapenemase-producing Enterobacterales: The impact of cytomegalovirus disease and lymphopenia.. Am J Transplant.
Delhaes, L., Touati K., Faure-Cognet O., Cornet M., Botterel F., Dannaoui E., et al. (2019).  Prevalence, geographic risk factor, and development of a standardized protocol for fungal isolation in cystic fibrosis: Results from the international prospective study "MFIP".. J Cyst Fibros. 18(2), 212-220.
Roilides, E., Carlesse F., Leister-Tebbe H., Conte U., Yan J. L., Liu P., et al. (2019).  A Prospective, Open-label Study to Assess the Safety, Tolerability and Efficacy of Anidulafungin in the Treatment of Invasive Candidiasis in Children 2 to <18 Years of Age.. Pediatr Infect Dis J. 38(3), 275-279.
Darda, V. Magdalini, Iosifidis E., Antachopoulos C., Volakli E., Haidich A. Bettina, Vagdatli E., et al. (2019).  Risk factors for carbapenem resistance and outcomes when treating bloodstream infections in a paediatric intensive care unit.. Acta Paediatr. 108(10), 1923-1924.
Bradley, J. S., Roilides E., Broadhurst H., Cheng K., Huang L-M., MasCasullo V., et al. (2019).  Safety and Efficacy of Ceftazidime-Avibactam in the Treatment of Children ≥3 Months to <18 Years With Complicated Urinary Tract Infection: Results from a Phase 2 Randomized, Controlled Trial.. Pediatr Infect Dis J. 38(9), 920-928.
Folgori, L., Lutsar I., Standing J. F., A Walker S., Roilides E., Zaoutis T. E., et al. (2019).  Standardising neonatal and paediatric antibiotic clinical trial design and conduct: the PENTA-ID network view.. BMJ Open. 9(12), e032592.
Athanasiadou, K. I., Athanasiadis D. I., Constantinidis J., Anastasiou A., Roilides E., & Papakonstantinou E. (2019).  Successful treatment of rhinoorbital mucormycosis due to Rhizopus arrhizus with liposomal amphotericin B, posaconazole and surgical debridement in a child with neuroblastoma.. Med Mycol Case Rep. 25, 10-14.
Roilides, I., Vasilaki K., Xinias I., Iosifidis E., Antachopoulos C., & Roilides E. (2019).  Thiamine Deficiency in a Child with Short Bowel Syndrome and Review.. Pediatr Gastroenterol Hepatol Nutr. 22(5), 493-499.
Iosifidis, E., Chorafa E., Agakidou E., Kontou A., Violaki A., Volakli E., et al. (2019).  Use of Ceftazidime-avibactam for the Treatment of Extensively drug-resistant or Pan drug-resistant Klebsiella pneumoniae in Neonates and Children <5 Years of Age.. Pediatr Infect Dis J. 38(8), 812-815.
2018
Iosifidis, E., Papachristou S., & Roilides E. (2018).  Advances in the Treatment of Mycoses in Pediatric Patients.. J Fungi (Basel). 4(4), 
Zoran, T., Sartori B., Sappl L., Aigner M., Sánchez-Reus F., Rezusta A., et al. (2018).  Azole-Resistance in and Related Species: An Emerging Problem or a Rare Phenomenon?. Front Microbiol. 9, 516.
Zoran, T., Sartori B., Sappl L., Aigner M., Sánchez-Reus F., Rezusta A., et al. (2018).  Corrigendum: Azole-Resistance in and Related Species: An Emerging Problem or a Rare Phenomenon?. Front Microbiol. 9, 3245.
Gholinejad-Ghadi, N., Shokohi T., Seifi Z., Aghili S. Reza, Roilides E., Nikkhah M., et al. (2018).  Identification of Mucorales in patients with proven invasive mucormycosis by polymerase chain reaction in tissue samples.. Mycoses. 61(12), 909-915.
Pyrpasopoulou, A., Pitsava G., Iosifidis E., Imvrios G., Massa E., Mouloudi E., et al. (2018).  Intravenous fosfomycin in patients with liver disease for extensively drug-resistant Gram-negative bacteria.. J Infect. 77(5), 448-454.
Pana, Z. Dorothea, Kotzadamis D., & Roilides E. (2018).  Invasive Candidiasis in Pediatric Intensive Care Unit: More Challenges.. Pediatr Infect Dis J. 37(12), 1309-1311.
Karampatakis, T., Antachopoulos C., Tsakris A., & Roilides E. (2018).  Molecular epidemiology of carbapenem-resistant Pseudomonas aeruginosa in an endemic area: comparison with global data.. Eur J Clin Microbiol Infect Dis. 37(7), 1211-1220.
Simitsopoulou, M., Chlichlia K., Kyrpitzi D., Walsh T. J., & Roilides E. (2018).  Pharmacodynamic and Immunomodulatory Effects of Micafungin on Host Responses against Biofilms of Candida parapsilosis in Comparison to Those of Candida albicans.. Antimicrob Agents Chemother. 62(8), 
Antachopoulos, C., Ilia S., Kadiltzoglou P., Baira E., Dokoumetzidis A., Gikas E., et al. (2018).  Pharmacokinetics of Daptomycin in Critically Ill Pediatric Patients.. Antimicrob Agents Chemother. 62(6), 
McCarthy, M. W., Katragkou A., Iosifidis E., Roilides E., & Walsh T. J. (2018).  Recent Advances in the Treatment of Scedosporiosis and Fusariosis.. J Fungi (Basel). 4(2), 
Kourkouni, E., Kourlaba G., Chorianopoulou E., Tsopela G-C., Kopsidas I., Spyridaki I., et al. (2018).  Surveillance for central-line-associated bloodstream infections: Accuracy of different sampling strategies.. Infect Control Hosp Epidemiol. 39(10), 1210-1215.
Robert-Gangneux, F., Meroni V., Dupont D., Botterel F., Garcia J. M. Aguado, Brenier-Pinchart M-P., et al. (2018).  Toxoplasmosis in Transplant Recipients, Europe, 2010-2014.. Emerg Infect Dis. 24(8), 1497-1504.
Iosifidis, E., Pitsava G., & Roilides E. (2018).  Ventilator-associated pneumonia in neonates and children: a systematic analysis of diagnostic methods and prevention.. Future Microbiol. 13, 1431-1446.
Pana, Z. Dorothea, Kourti M., Vikelouda K., Vlahou A., Katzilakis N., Papageorgiou M., et al. (2018).  Voriconazole Antifungal Prophylaxis in Children With Malignancies: A Nationwide Study.. J Pediatr Hematol Oncol. 40(1), 22-26.

Σελίδες

Επικοινωνία

Τμήμα Ιατρικής, Πανεπιστημιούπολη ΑΠΘ, T.K. 54124, Θεσσαλονίκη
 

Συνδεθείτε

Το τμήμα Ιατρικής στα κοινωνικά δίκτυα.
Ακολουθήστε μας ή συνδεθείτε μαζί μας.

           

Σύνδεσμοι

 

Το πανεπιστήμιο

 
 

Προσωπικό & Φοιτητές